ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,655Medicare Part D Prescriptions Filled, Including Refills

Rank: 146 out of 617

$319K Total Retail Price of All Prescriptions

Rank: 223 out of 617

382 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 382 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 382 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 6,921 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
WARFARIN SODIUM 367 321 1 7
SIMVASTATIN 344 276 2 2
LEVOTHYROXINE SODIUM 319 256 3 1
AMLODIPINE BESYLATE 283 279 4 6
HYDROCODONE-ACETAMINOPHEN 259 208 S3 5 8
POTASSIUM CHLORIDE 248 213 6 10
FUROSEMIDE 231 219 7 4
OMEPRAZOLE 231 207 7 3
LISINOPRIL 223 190 9 5
METFORMIN HCL 194 149 10 9
ZOLPIDEM TARTRATE 173 123 11 23
CITALOPRAM HBR 153 96 12 18
ATORVASTATIN CALCIUM 143 131 13 14
CARVEDILOL 134 119 14 19
SERTRALINE HCL 130 107 15 20
METOPROLOL SUCCINATE 128 128 16 12
TORSEMIDE 124 85 17 110
LOSARTAN POTASSIUM 113 102 18 22
TRAMADOL HCL 108 53 19 15
METOPROLOL TARTRATE 97 97 20 11
DIGOXIN 96 96 21 48
HYDROCHLOROTHIAZIDE 95 62 22 13
ALENDRONATE SODIUM 94 57 23 25
DILTIAZEM 24HR CD 94 82 23 117
PREDNISONE 92 88 25 31
ATENOLOL 92 82 25 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 90 77 27 29
ADVAIR DISKUS 88 76 28 38
POLYETHYLENE GLYCOL 3350 86 54 29 32
BISOPROLOL-HYDROCHLOROTHIAZIDE 85 73 30 87
TAMSULOSIN HCL 75 75 31 26
PANTOPRAZOLE SODIUM 70 50 32 37
GABAPENTIN 69 57 33 16
CYCLOBENZAPRINE HCL 68 0 R 34 74
OXYBUTYNIN CHLORIDE ER 65 53 35 114
CYMBALTA 65 37 35 49
AMOX TR-POTASSIUM CLAVULANATE 60 43 37 184
VENLAFAXINE HCL ER 58 20 38 76
KLOR-CON M20 57 48 39 116
LIPITOR 56 43 40 118
LEVOFLOXACIN 56 47 40 89
ENALAPRIL MALEATE 54 42 42 34
FLUTICASONE PROPIONATE 51 27 43 36
CRESTOR 51 51 43 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.